Drugs in R&D

Drugs in R&D publishes original research and reviews from all phases of drug development and on the clinical use of drugs following approval.

Articles published in Drugs in R&D may be accompanied by plain language summaries, to assist patients, caregivers  and others in understanding important medical advances.

The journal was re-launched in 2010 as the first Open Access journal from Adis, making all content from 2010 onwards freely available online. Pre-2010 content is not available as Open Access.

Manuscripts submitted to the journal for publication will be subject to a $US3,000 / €2,200 article processing charge (APC) upon acceptance. Adis Open Access enables you to make your journal article freely available to anyone, in exchange for payment of APC. This option allows you, the author, to retain the copyright of the article according to the terms of the Creative Commons Attribution Non-Commercial (CC BY-NC) License, which does not permit commercial re-use of the article. 

The journal will consider fee discounts for developing countries and this is decided on a case by case basis.